4//SEC Filing
Remmel H. Lawrence 4
Accession 0000950170-25-046742
CIK 0001488039other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:00 PM ET
Size
4.8 KB
Accession
0000950170-25-046742
Insider Transaction Report
Form 4
Remmel H. Lawrence
Director
Transactions
- Purchase
Common Stock
2025-03-26$0.70/sh+10,000$7,000→ 10,257 total
Footnotes (1)
- [F1]Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001551817
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:00 PM ET
- Size
- 4.8 KB